Target Name: MIR6862-1
NCBI ID: G102465520
Other Name(s): microRNA 6862-1 | hsa-miR-6862-3p | hsa-miR-6862-5p | MicroRNA 6862-1 | hsa-mir-6862-1

MIR6862-1: A Potential Drug Target and Biomarker for Cancer

MicroRNA 6862-1 (MIR6862-1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR6862-1 is a key regulator of cell proliferation and has been shown to play a role in the development and progression of various diseases.

The discovery of MIR6862-1 began in 2006 when a research team led by Dr. Yueh-Fen Tsai at the University of California, San Diego identified a highly conserved RNA molecule that was highly expressed in various tissues and organs, including brain, heart, and pancreas. The team named the molecule MIR6862-1 and predicted its function as a potential regulator of gene expression.

Since its discovery, MIR6862-1 has been shown to play a critical role in the development and progression of various diseases, including cancer. Studies have shown that MIR6862-1 is highly expressed in various cancer types, including breast, ovarian, and colorectal cancers. Additionally, MIR6862-1 has been shown to play a role in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer.

MIR6862-1 has also been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached their maximum lifespan. Studies have shown that MIR6862-1 can induce cell apoptosis in various cell types, including cancer cells. This suggests that MIR6862-1 may be a useful drug target or biomarker for cancer treatment.

In addition to its role in cell apoptosis, MIR6862-1 has also been shown to play a role in the regulation of cell migration. Studies have shown that MIR6862-1 can regulate the migration of various cell types, including cancer cells. This suggests that MIR6862-1 may be a useful drug target or biomarker for the treatment of various diseases, including cancer.

MIR6862-1 has also been shown to play a role in the regulation of cell proliferation. Studies have shown that MIR6862-1 can regulate the proliferation of various cell types, including cancer cells. This suggests that MIR6862-1 may be a useful drug target or biomarker for the treatment of various diseases, including cancer.

In conclusion, MIR6862-1 is a non-coding RNA molecule that has been shown to play a critical role in the development and progression of various diseases, including cancer. The discovery of MIR6862-1 has the potential to lead to new drug development and diagnostic tools for the treatment of various diseases. Further research is needed to fully understand the role of MIR6862-1 in disease progression and to develop effective treatments.

Protein Name: MicroRNA 6862-1

More Common Targets

MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054